Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Zenarestat

Copy Product Info
😃Good
Catalog No. T35299Cas No. 112733-06-9
Alias FR-74366, FR74366, FR 74366, CI-1014, CI1014

Zenarestat is an orally active aldose reductase inhibitor capable of ameliorating diabetic peripheral neuropathy in rats with type 2 diabetes.

Zenarestat

Zenarestat

Copy Product Info
😃Good
Purity: 99.51%
Catalog No. T35299Alias FR-74366, FR74366, FR 74366, CI-1014, CI1014Cas No. 112733-06-9
Zenarestat is an orally active aldose reductase inhibitor capable of ameliorating diabetic peripheral neuropathy in rats with type 2 diabetes.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$149-In Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.51%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
Zenarestat is an orally active aldose reductase inhibitor capable of ameliorating diabetic peripheral neuropathy in rats with type 2 diabetes.
In vivo
Methods: Zenarestat (3.2 mg/kg and 32 mg/kg, once daily for 8 consecutive weeks) was orally administered to Zucker diabetic fatty (ZDF) rats to investigate the effects of zenarestat on peripheral neuropathy in the type 2 diabetes animal model ZDF rats.
Results: At the dose of 3.2 mg/kg, zenarestat did not show significant effects on FML latency delay and MNCV slowing; however, at the dose of 32 mg/kg, zenarestat treatment significantly improved these neurologic disorders in ZDF rats and reduced the accumulation of sorbitol in nerves to levels nearly equivalent to those in lean rats.[3]
SynonymsFR-74366, FR74366, FR 74366, CI-1014, CI1014
Chemical Properties
Molecular Weight441.64
FormulaC17H11BrClFN2O4
Cas No.112733-06-9
SmilesO=C(O)CN1C(=O)N(C(=O)C2=CC=C(Cl)C=C21)CC3=CC=C(Br)C=C3F
Relative Density.1.31g/cm3
Storage & Solubility Information
Storagestore at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 80 mg/mL (181.14 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.2643 mL11.3214 mL22.6429 mL113.2144 mL
5 mM0.4529 mL2.2643 mL4.5286 mL22.6429 mL
10 mM0.2264 mL1.1321 mL2.2643 mL11.3214 mL
20 mM0.1132 mL0.5661 mL1.1321 mL5.6607 mL
50 mM0.0453 mL0.2264 mL0.4529 mL2.2643 mL
100 mM0.0226 mL0.1132 mL0.2264 mL1.1321 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Zenarestat | purchase Zenarestat | Zenarestat cost | order Zenarestat | Zenarestat chemical structure | Zenarestat in vivo | Zenarestat formula | Zenarestat molecular weight